Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier

Biomaterials

Volumn 35, Issue 8, 2014, Pages 2507-2517

  Min, Jouha ^a,b   Braatz, Richard D ^a   Hammond, Paula T ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b David H Koch Institute for Integrative Cancer Research   (United States)

Author keywords

Antibacterial; BMP (bone morphogenetic protein); Bone; Controlled drug release; Layer by layer; Silicate

Indexed keywords

ANTIBACTERIAL; BMP (BONE MORPHOGENETIC PROTEIN); BONE MORPHOGENETIC PROTEIN-2; CONTROLLED DRUG RELEASE; LAYER-BY-LAYER APPROACHES; LAYER-BY-LAYERS; MULTI-LAYERED COATINGS; TISSUE ENGINEERING SCAFFOLD;

BIOMIMETICS; BONE; COMPOSITE COATINGS; COMPOSITE FILMS; DRUG PRODUCTS; FUNCTIONAL POLYMERS; SCAFFOLDS (BIOLOGY); SILICATES;

DIFFUSION BARRIERS;

ANTIBIOTIC AGENT; BIOMIMETIC MATERIAL; BONE MORPHOGENETIC PROTEIN 2; GENTAMICIN; POLYMER; SELF ASSEMBLED MONOLAYER;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CLAY; COMPOSITE MATERIAL; DIFFUSION; IN VITRO STUDY; LAYER BY LAYER COATING; MATERIAL COATING; ORTHOPEDIC IMPLANT; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

ANTIBACTERIAL; BMP (BONE MORPHOGENETIC PROTEIN); BONE; CONTROLLED DRUG RELEASE; LAYER-BY-LAYER; SILICATE;

3T3 CELLS; ALUMINUM SILICATES; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG RESISTANCE, BACTERIAL; GENTAMICINS; MICE; POLYMERS; STAPHYLOCOCCUS AUREUS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84891736128     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.009     Document Type: Article

References (55)

1. Hammond P.T. Polyelectrolyte multilayered nanoparticles: using nanolayers for controlled and targeted systemic release. Nanomed 2012, 7:619-622.
2. Sundararaj S.C., Thomas M.V., Peyyala R., Dziubla T.D., Puleo D.A. Design of a multiple drug delivery system directed at periodontitis. Biomaterials 2013, 34:8835-8842.
3. Chen F.-M., Zhang M., Wu Z.-F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
4. Hammond P.T. Form and function in multilayer assembly: new applications at the nanoscale. Adv Mater 2004, 16:1271-1293.
5. DeMuth P.C., Min Y., Huang B., Kramer J.A., Miller A.D., Barouch D.H., et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater 2013, 12:367-376.
6. Morton S.W., Poon Z., Hammond P.T. The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials 2013, 34:5328-5335.
7. Poon Z., Chang D., Zhao X., Hammond P.T. Layer-by-layer nanoparticles with a pH-sheddable layer for invivo targeting of tumor hypoxia. ACS Nano 2011, 5:4284-4292.
8. Tang Z., Wang Y., Podsiadlo P., Kotov N.A. Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering. Adv Mater 2006, 18:3203-3224.
9. Hong J., Shah N.J., Drake A.C., DeMuth P.C., Lee J.B., Chen J., et al. Graphene multilayers as gates for multi-week sequential release of proteins from surfaces. ACS Nano 2011, 6:81-88.
10. Kim B.S., Smith R.C., Poon Z., Hammond P.T. MAD (multiagent delivery) nanolayer: delivering multiple therapeutics from hierarchically assembled surface coatings. Langmuir 2009, 25:14086-14092.
11. Barthes J., Mertz D., Bach C., Metz-Boutigue M-Hln, Senger B., Voegel J.-C., et al. Stretch-induced biodegradation of polyelectrolyte multilayer films for drug release. Langmuir 2012, 28:13550-13554.
12. Labek G., Thaler M., Janda W., Agreiter M., Stöckl B. Revision rates after total joint replacement: cumulative results from worldwide joint register datasets. JBone Joint Surg 2011, 93:293-297.
13. Hebert C.K., Williams R.E., Levy R.S., Barrack R.L. Cost of treating an infected total knee replacement. Clin Orthop 1996, 331:140.
14. Wenke J.C., Guelcher S.A. Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures. Expert Opin Drug Deliv 2011, 8:1555-1569.
15. Nguyen A., Kim S., Maloney W., Wenke J., Yang Y. Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells invitro. Antimicrob Agents Chemother 2012, 56:3776-3784.
16. Goodman S.B., Yao Z., Keeney M., Yang F. The future of biologic coatings for orthopaedic implants. Biomaterials 2013, 34:3174-3183.
17. Moskowitz J.S., Blaisse M.R., Samuel R.E., Hsu H.P., Harris M.B., Martin S.D., et al. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials 2010, 31:6019-6030.
18. Shah N.J., Macdonald M.L., Beben Y.M., Padera R.F., Samuel R.E., Hammond P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011, 32:6183-6193.
19. Shah N.J., Hong J., Hyder M.N., Hammond P.T. Osteophilic multilayer coatings for accelerated bone tissue growth. Adv Mater 2012, 24:1445-1450.
20. Shah N.J., Hyder M.N., Moskowitz J.S., Quadir M.A., Morton S.W., Seeherman H.J., et al. Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings. Sci Transl Med 2013, 5:191ra83.
21. Macdonald M.L., Samuel R.E., Shah N.J., Padera R.F., Beben Y.M., Hammond P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32:1446-1453.
22. Picart C., Mutterer J., Richert L., Luo Y., Prestwich G., Schaaf P., et al. Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers. Proc Natl Acad Sci 2002, 99:12531-12535.
23. Hammond P.T. Engineering materials layer-by-layer: challenges and opportunities in multilayer assembly. AIChE J 2011, 57:2928-2940.
24. Min Y., Hammond P.T. Catechol-modified polyions in layer-by-layer assembly to enhance stability and sustain release of biomolecules: a bioinspired approach. Chem Mater 2011, 23:5349-5357.
25. Wood K.C., Chuang H.F., Batten R.D., Lynn D.M., Hammond P.T. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc Natl Acad Sci 2006, 103:10207-10212.
26. Garza J.M., Schaaf P., Muller S., Ball V., Stoltz J.-F., Voegel J.-C., et al. Multicompartment films made of alternate polyelectrolyte multilayers of exponential and linear growth. Langmuir 2004, 20:7298-7302.
27. Mertz D., Vogt C., Hemmerlé J., Mutterer J., Ball V., Voegel J.-C., et al. Mechanotransductive surfaces for reversible biocatalysis activation. Nat Mater 2009, 8:731-735.
28. Wang K., Ruan J., Song H., Zhang J., Wo Y., Guo S., et al. Biocompatibility of graphene oxide. Nanoscale Res Lett 2011, 6:1-8.
29. Li Y., Maciel D., Tomás H., Rodrigues J., Ma H., Shi X. pH sensitive laponite/alginate hybrid hydrogels: swelling behaviour and release mechanism. Soft Matter 2011, 7:6231-6238.
30. Gaharwar A.K., Mihaila S.M., Swami A., Patel A., Sant S., Reis R.L., et al. Bioactive silicate nanoplatelets for osteogenic differentiation of human mesenchymal stem cells. Adv Mater 2013, 25:3329-3336.
31. ® cross-linked poly (ethylene oxide) for controlled cell adhesion and mineralization. Acta Biomater 2011, 7:568-577.
32. Viseras C., Aguzzi C., Cerezo P., Bedmar M. Biopolymer-clay nanocomposites for controlled drug delivery. Mater Sci Tech 2008, 24:1020-1026.
33. Takahashi T., Yamada Y., Kataoka K., Nagasaki Y. Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles. JControl Release 2005, 107:408-416.
34. Cypes S.H., Saltzman W.M., Giannelis E.P. Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties. JControl Release 2003, 90:163-169.
35. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Montmorillonite as a drug delivery system: intercalation and invitro release of timolol maleate. Int J Pharm 2009, 374:53-57.
36. Liu L., Grunlan J.C. Clay assisted dispersion of carbon nanotubes in conductive epoxy nanocomposites. Adv Funct Mater 2007, 17:2343-2348.
37. Podsiadlo P., Kaushik A.K., Arruda E.M., Waas A.M., Shim B.S., Xu J., et al. Ultrastrong and stiff layered polymer nanocomposites. Science 2007, 318:80-83.
38. Lynn D.M., Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. JAm Chem Soc 2000, 122:10761-10768.
39. Chuang H.F., Smith R.C., Hammond P.T. Polyelectrolyte multilayers for tunable release of antibiotics. Biomacromolecules 2008, 9:1660-1668.
40. Gregory C.A., Grady Gunn W., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329:77-84.
41. Pashuck E.T., Stevens M.M. Designing regenerative biomaterial therapies for the clinic. Sci Transl Med 2012, 4:160sr4.
42. Andrews J.M. Determination of minimum inhibitory concentrations. JAntimicrob Chemother 2001, 48:5-16.
43. Isefuku S., Joyner C.J., Simpson A.H.R. Gentamicin may have an adverse effect on osteogenesis. JOrthop Trauma 2003, 17:212-216.
44. Daghighi S., Sjollema J., van der Mei H.C., Busscher H.J., Rochford E.T. Infection resistance of degradable versus non-degradable biomaterials: an assessment of the potential mechanisms. Biomaterials 2013, 34:8013-8017.
45. Lutkenhaus J.L., Olivetti E.A., Verploegen E.A., Cord B.M., Sadoway D.R., Hammond P.T. Anisotropic structure and transport in self-assembled layered polymer-clay nanocomposites. Langmuir 2007, 23:8515-8521.
46. Fornes T., Paul D. Modeling properties of nylon 6/clay nanocomposites using composite theories. Polymer 2003, 44:4993-5013.
47. Paul D., Robeson L. Polymer nanotechnology: nanocomposites. Polymer 2008, 49:3187-3204.
48. Zilberman M., Elsner J.J. Antibiotic-eluting medical devices for various applications. JControl Release 2008, 130:202-215.
49. Macdonald M., Rodriguez N.M., Smith R., Hammond P.T. Release of a model protein from biodegradable self assembled films for surface delivery applications. JControl Release 2008, 131:228-234.
50. Jeon O., Song S.J., Yang H.S., Bhang S.-H., Kang S.-W., Sung M., et al. Long-term delivery enhances invivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 2008, 369:774-780.
51. Groeneveld E., Burger E. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000, 142:9-21.
52. Zara J.N., Siu R.K., Zhang X., Shen J., Ngo R., Lee M., et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation invivo. Tissue Eng Part A 2011, 17:1389-1399.
53. Wenzel R.P., Bratzler D., Hunt D., van Rijen M., Bonten M., Wenzel R., et al. Minimizing surgical-site infections. NEngl J Med 2010, 11:75-77.
54. Soundrapandian C., Datta S., Sa B. Drug-eluting implants for osteomyelitis. Crit Rev Ther Drug Carrier Syst 2007, 24:493-545.
55. Darouiche R.O., Mansouri M.D., Zakarevicz D., AlSharif A., Landon G.C. Invivo efficacy of antimicrobial-coated devices. JBone Joint Surg 2007, 89:792-797.